T-non-Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch T-non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells (NCT03690011) | Baylor College of Medicine | 2021-08-02 |
| Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (NCT03081910) | Baylor College of Medicine | 2017-11-01 |
Track T-non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.